Dr. Isaac Silverman, M.D

NPI: 1326058108
Total Payments
$75,489
2024 Payments
$1,018
Companies
50
Transactions
325
Medicare Patients
1,002
Medicare Billing
$112,004

Payment Breakdown by Category

Consulting$70,596 (93.5%)
Food & Beverage$4,702 (6.2%)
Other$191.36 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $70,596 52 93.5%
Food and Beverage $4,702 262 6.2%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $191.36 11 0.3%

Top Paying Companies

Company Total Records Latest Year
PFIZER INC. $70,695 59 $0 (2024)
Novartis Pharmaceuticals Corporation $619.31 47 $0 (2024)
MDD US Operations, LLC $295.49 7 $0 (2024)
UCB, Inc. $263.72 10 $0 (2024)
GENZYME CORPORATION $240.63 12 $0 (2023)
Biogen, Inc. $234.17 16 $0 (2024)
Teva Pharmaceuticals USA, Inc. $203.98 18 $0 (2020)
Acorda Therapeutics, Inc $191.36 11 $0 (2019)
ACADIA Pharmaceuticals Inc $172.44 10 $0 (2023)
Genentech USA, Inc. $167.34 9 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,018 43 MDD US Operations, LLC ($295.49)
2023 $440.95 31 Novartis Pharmaceuticals Corporation ($197.31)
2022 $98.55 5 ABBVIE INC. ($29.97)
2021 $219.24 9 Janssen Pharmaceuticals, Inc ($56.87)
2020 $1,898 17 PFIZER INC. ($1,522)
2019 $19,158 53 PFIZER INC. ($18,460)
2018 $27,022 71 PFIZER INC. ($26,203)
2017 $25,634 96 PFIZER INC. ($24,483)

All Payment Transactions

325 individual payment records from CMS Open Payments — Page 1 of 13

Date Company Product Nature Form Amount Type
12/13/2024 ABBVIE INC. QULIPTA (Drug), BOTOX Food and Beverage In-kind items and services $18.94 General
Category: NEUROSCIENCE
12/03/2024 PFIZER INC. OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA Food and Beverage In-kind items and services $26.68 General
Category: IMMUNOLOGY
11/27/2024 Genentech USA, Inc. Ocrevus Zunovo (Biological) Food and Beverage In-kind items and services $17.18 General
Category: Immunology
11/22/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $22.47 General
Category: Neurology
11/06/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $23.76 General
Category: Neurology
10/30/2024 Takeda Pharmaceuticals U.S.A., Inc. HYQVIA (Biological) Food and Beverage In-kind items and services $18.03 General
Category: IMMUNOLOGY
10/22/2024 Genentech USA, Inc. Ocrevus Zunovo (Biological) Food and Beverage In-kind items and services $34.83 General
Category: Immunology
10/16/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $28.73 General
Category: Neurology
09/18/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $29.14 General
Category: Neurology
09/11/2024 Grifols USA, LLC Gamunex-C (Biological) Food and Beverage In-kind items and services $23.70 General
Category: Immunology and Neurology
08/30/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $15.21 General
Category: Neuroscience
08/15/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $21.00 General
Category: Neuroscience
08/14/2024 Takeda Pharmaceuticals U.S.A., Inc. HYQVIA (Biological) Food and Beverage In-kind items and services $22.37 General
Category: IMMUNOLOGY
07/25/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $19.00 General
Category: Neurology
07/24/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $4.47 General
Category: Neurology
07/09/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $3.95 General
Category: Neurology
06/11/2024 Biogen, Inc. VUMERITY (Drug) Food and Beverage In-kind items and services $28.43 General
Category: Neurology
06/04/2024 MDD US Operations, LLC Gocovri (Drug) Food and Beverage In-kind items and services $15.49 General
Category: AMANTADINE
06/03/2024 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $37.80 General
Category: Neurology
05/20/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $22.59 General
Category: Neurology
05/20/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $1.18 General
Category: Neurology
05/15/2024 Genentech USA, Inc. Ocrevus (Biological) Food and Beverage In-kind items and services $18.40 General
Category: Immunology
05/13/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $3.72 General
Category: Neurology
05/07/2024 Neurelis, Inc. VALTOCO (Drug) Food and Beverage In-kind items and services $20.19 General
Category: EPILEPSY
05/03/2024 MDD US Operations, LLC Gocovri (Drug) Food and Beverage In-kind items and services $13.43 General
Category: AMANTADINE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 204 227 $56,071 $20,565
2022 9 249 290 $82,333 $29,279
2021 7 245 286 $77,816 $29,357
2020 8 304 322 $88,168 $32,803
Total Patients
1,002
Total Services
1,125
Medicare Billing
$112,004
Procedure Codes
31

All Medicare Procedures & Services

31 procedure records from CMS Medicare Utilization — Page 2 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99221 Initial hospital inpatient care, typically 30 minutes per day Facility 2020 57 57 $15,561 $4,968 31.9%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 35 35 $12,880 $4,171 32.4%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 31 38 $10,602 $3,431 32.4%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 31 37 $7,178 $2,275 31.7%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 17 17 $5,406 $2,273 42.0%
99238 Hospital discharge day management, 30 minutes or less Facility 2020 11 11 $2,167 $637.16 29.4%

About Dr. Isaac Silverman, M.D

Dr. Isaac Silverman, M.D is a Vascular Neurology healthcare provider based in Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326058108.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Isaac Silverman, M.D has received a total of $75,489 in payments from pharmaceutical and medical device companies, with $1,018 received in 2024. These payments were reported across 325 transactions from 50 companies. The most common payment nature is "Consulting Fee" ($70,596).

As a Medicare-enrolled provider, Silverman has provided services to 1,002 Medicare beneficiaries, totaling 1,125 services with total Medicare billing of $112,004. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.

Practice Information

  • Specialty Vascular Neurology
  • Location Hartford, CT
  • Active Since 08/08/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 2084V0102X
  • Entity Type Individual
  • NPI Number 1326058108

Products in Payments

  • STEGLATRO (Drug) $43,987
  • KESIMPTA (Drug) $399.87
  • Gocovri (Drug) $295.49
  • NUPLAZID (Drug) $172.44
  • RYTARY (Drug) $152.99
  • COPAXONE (Drug) $152.72
  • AMPYRA (Drug) $143.91
  • APTIOM (Drug) $131.74
  • ANDEXXA (Biological) $130.49
  • Hizentra (Biological) $127.21
  • NUEDEXTA (Drug) $125.08
  • TYSABRI (Biological) $122.37
  • AIMOVIG (Biological) $112.07
  • Briviact (Drug) $107.93
  • Aimovig (Biological) $105.54
  • Gamunex-C (Biological) $98.99
  • Vimpat (Drug) $89.77
  • TROKENDI XR (Drug) $84.39
  • TECFIDERA (Drug) $83.37
  • AUBAGIO (Drug) $81.63

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Vascular Neurology Doctors in Hartford